JPEO-CBRND & BARDA Commercial Solutions Opening (CSO) Area of Interest (AoI) W911QY-20-S-C001-A002 Neutralization Assay

The Biomedical Advanced Research and Development Authority (BARDA), under the Department of Health and Human Services, seeks neutralization assay services to support COVID-19 vaccine and therapeutic development efforts through a technology transfer of a validated SARS-CoV-2 neutralization assay to a new Biosafety Level 3 laboratory for validation and subsequent testing of approximately 1,000 clinical trial samples per week over 12 months. Offerors must have BSL3 facilities and experience conducting live virus neutralization assays and testing under GLP/GCLP conditions. Solution briefs must be submitted by July 31, 2020 in response to solicitation number W911QY-20-S-C001-A002, with the Army Contracting Command evaluating technical qualifications, validation protocols, and ability to meet urgent testing capacity requirements.

There is no set-aside designation. The primary NAICS code is 541715 and PSC code is R425. Services will be performed in Natick, MA for 12 months under any potential award(s). The government seeks to make multiple firm fixed price contract awards totaling an unknown value to meet Operation Warp Speed initiative's urgent requirements. Offerors must propose a minimum weekly testing capacity of 1,000 samples and have full capacity available by October 30, 2020.